Skip to main content
OpenTrials

Clinical trial condition

Spondylarthropathies

Explore clinical trials studying Spondylarthropathies. Study availability and eligibility vary by location and protocol.

825 public trials 129 recruiting studies
Refine in advanced search Browse all conditions

Spondylarthropathies trial results

Completed

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

NCT01976364

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +14 more
Locations
  • Rheumatology Associates, PC Birmingham, Alabama, United States
  • Rheumatology Associates of North Alabama, PC Huntsville, Alabama, United States
  • Arizona Arthritis & Rheumatology Associates, P.C. Glendale, Arizona, United States
  • St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare Fullerton, California, United States
View all 153 locations
View Trial Details
Completed

Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis

NCT01752634

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +12 more
Locations
  • Novartis Investigative Site Peoria, Arizona, United States
  • Novartis Investigative Site Aventura, Florida, United States
  • Novartis Investigative Site Palm Harbor, Florida, United States
  • Novartis Investigative Site Sarasota, Florida, United States
View all 76 locations
View Trial Details
Completed

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

NCT01925768

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations
  • Achieve Clinical Research LLC Birmingham, Alabama, United States
  • Desert Medical Advances Palm Desert, California, United States
  • Bay Area Arthritis and Osteoporosis Brandon, Florida, United States
  • Health Point Medical Group Brandon, Florida, United States
View all 71 locations
View Trial Details
Completed

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

NCT01988103

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +12 more
Locations
  • Ekihigashi Hifuka Clinic Fukuoka, Japan
  • Tsutsui Clinic Dermatology & Plastic Surgery Fukuoka, Japan
  • Yano Hifuka Hinyokika Clini Fukuoka, Japan
  • Fukuoka University Hospital Fukuoka, Japan
View all 56 locations
View Trial Details
Completed

PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

NCT01212770

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Elite Clinical Studies, LLC Phoenix, Arizona, United States
  • Catalina Pointe Clinical Research Incorporated Tucson, Arizona, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
View all 91 locations
View Trial Details
Completed

PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

NCT01212757

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +14 more
Locations
  • Clinical and Translational Research Center of Alabama, PC Tuscaloosa, Alabama, United States
  • Denver Arthritis Clinic Denver, Colorado, United States
  • New England Research Associates, LLC Trumbull, Connecticut, United States
  • Centre For Rheumatology, Immun. And Arthritis Fort Lauderdale, Florida, United States
View all 98 locations
View Trial Details
Completed

Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis

NCT02404350

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Novartis Investigative Site Upland, California, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Denver, Colorado, United States
  • Novartis Investigative Site Brandon, Florida, United States
View all 172 locations
View Trial Details

Related conditions